Latest news about Capillary Technologies
Capillary Technologies Q1 Results: Revenue jumps to 2.56B rupees QoQ
Capillary Technologies
528.55
+5.60(+1.07%)
Company Performance:
View Company Insights1D+1.07%
1M+4.86%
6M-8.48%
1Y-12.85%
5Y-12.85%
More news about Capillary Technologies
04Aug 26
Capillary Technologies hosts analyst meet at Emkay Confluence 2026
Capillary Technologies India Limited announced a group meeting with analysts and institutional investors scheduled for August 12, 2026, as part of the Emkay Confluence 2026 conference. The physical event allows market participants to engage with management on business strategy, ensuring compliance with SEBI Listing Regulations by disclosing that no UPSI will be discussed.
02Aug 26
Capillary Technologies publishes 14th AGM notice in newspapers
Capillary Technologies India Limited confirmed the publication of its 14th AGM notice in major newspapers on August 2, 2026, ensuring compliance with SEBI regulations. The virtual meeting on August 28 will focus on FY26 results and director reappointments, with e-voting available via NSDL from August 24 to 27.
01Aug 26
Capillary Technologies files FY26 sustainability report with BSE, NSE
Capillary Technologies India Limited filed its FY26 BRSR report with BSE and NSE on August 01, 2026, disclosing standalone ESG metrics. The IT services firm reported a turnover of ₹2,118.90 mn, with exports contributing 93%. The workforce grew to 841 employees, with women comprising 26.27% of staff. Energy consumption from non-renewable sources rose to 108,222 units, while water consumption increased to 19,20,000 litres. The company resolved all 152 shareholder grievances and reported zero safety incidents or data breaches.
01Aug 26
Capillary Technologies FY26 Results: Consolidated PAT surges 295% YoY
Capillary Technologies India Limited reported a consolidated net profit of ₹523.88 million for FY26, up 295% YoY, with revenue rising 23% to ₹7,345.99 million. Standalone revenue grew 22% to ₹2,118.90 million, but standalone net profit fell to ₹28.90 million due to acquisition-related costs. The company raised ₹8,775.01 million via IPO and holds ₹4,830.00 million in cash.
31Jul 26
Capillary Technologies India Initiates Forensic Audit to Probe Suspected Fraudulent Banking Transactions
Capillary Technologies India has initiated a forensic audit to investigate suspected fraudulent banking transactions. The audit is being conducted by KPMG Assurance and Consulting Services LLP. The move reflects a formal corporate governance response to concerns over potential financial irregularities within the company's banking operations.
29Jul 26
Capillary Technologies India to Host Q1 FY27 Earnings Call on August 4
Capillary Technologies India Limited has scheduled its Q1 FY27 earnings conference call for August 4, 2026, at 4:00 PM IST, following the announcement of financial results for the quarter ended June 30, 2026. The disclosure was filed with BSE and NSE pursuant to SEBI (LODR) Regulations, 2015, and signed by Company Secretary Gireddy Bhargavi Reddy on July 28, 2026. Investors and analysts can register via the company's investor relations page or contact Rishi Ray at investorrelations@capillarytech.com for further details.
27Jul 26
Capillary Technologies India Ltd accepts Sunil M Jain resignation
Capillary Technologies India Limited disclosed the resignation of Sunil M Jain, Head - Corporate Development, effective July 31, 2026. The filing, made under SEBI Regulation 30, cites personal career opportunities as the reason for his departure. The company secretary confirmed the details to stock exchanges.
11Jul 26
Capillary Technologies India Limited to host virtual investor meet on July 15
Capillary Technologies India Limited will hold a virtual investor meeting on July 15, 2026. The company confirmed that no unpublished price sensitive information will be shared during the session.
02Jul 26
Capillary Technologies grants 7.45 lakh stock options to employees
Capillary Technologies India Limited granted 7,45,537 stock options to eligible employees under its ESOP Plan 2021 on July 01, 2026. The exercise price is ₹418 per option for general employees and ₹521.47 for US tax residents. Options vest over three to four years and are exercisable within 10 years of vesting or 12 years of listing.
10Jun 26
Capillary Technologies to attend Avendus Spark investor conference
Capillary Technologies India Limited will participate in the Small-Cap Investor Conference hosted by Avendus Spark on June 15, 2026, in Mumbai. The company confirmed that no unpublished price sensitive information will be discussed. The disclosure was submitted to the stock exchanges on June 10, 2026.
30May 26
Capillary Technologies fixes 14th AGM for August 28, 2026
Capillary Technologies India Limited has fixed August 28, 2026, as the date for its 14th Annual General Meeting, with August 21, 2026, as the cut-off date for shareholder eligibility. The Board approved the decision in a meeting held on May 29, 2026.
30May 26
Capillary Technologies Finance Head resigns effective June 05, 2026
Capillary Technologies India Limited disclosed that Mr. Ravi Jaswani, Head – Finance and Senior Management Personnel, resigned effective June 05, 2026, to pursue new opportunities. The regulatory filing submitted on May 29, 2026, confirms the cessation date and details the transition in financial leadership.
21May 26
Capillary Technologies schedules analyst meet on May 25
Capillary Technologies India Limited has scheduled a virtual analyst and institutional investor meeting for May 25, 2026. The company clarified that no Unpublished Price Sensitive Information will be shared during the interaction.
15May 26
Capillary Technologies India Limited Schedules Analyst and Institutional Investor Meet on May 20, 2026
Capillary Technologies India Limited has filed an intimation with BSE and NSE regarding a scheduled analyst and institutional investor meeting on Wednesday, May 20, 2026. The meeting will be held in a multiple one-on-one format at a physical venue in Mumbai. The company has noted that the schedule is subject to change and confirmed that no Unpublished Price Sensitive Information is intended to be discussed. The filing was made on May 15, 2026, by Company Secretary and Compliance Officer Gireddy Bhargavi Reddy.
12May 26
Capillary Tech FY26: PAT Surges 270%, Revenue Up 23%; Earnings Call Highlights FY27 Outlook
Capillary Technologies India Limited reported strong FY26 audited results with consolidated revenue rising 23% YoY to ₹7,345.99 million and PAT surging 270% to ₹523.88 million. The Q4 FY26 earnings call on May 06, 2026 provided additional context, with management highlighting 110% overall NRR, an ARR of ₹765 crores, new ACV of ₹121 crores, and FY27 revenue guidance of ₹1,000–1,050 crores driven by the SessionM acquisition and organic growth. The aiRA AI platform is gaining commercial traction, with approximately a fourth of customers piloting or paying for the stack, while steady-state EBITDA margins are targeted at 25%–30%.
08May 26
Capillary Technologies India Limited Analyst/Institutional Investor Meeting Intimation Under Regulation 30 Scheduled from May 12–15, 2026
Capillary Technologies India Limited notified stock exchanges on May 07, 2026, of a multi-day series of analyst and institutional investor meetings scheduled from May 12 to May 15, 2026, covering physical venues in Singapore and Mumbai. The filing, made under Regulation 30 of the SEBI Listing Regulations, confirms that no Unpublished Price Sensitive Information is intended to be discussed, and the schedule is subject to change.
02May 26
Capillary Technologies Completes Strategic Acquisition of Session M Companies
Capillary Technologies India Limited has successfully finalized the strategic acquisition of Session M Inc. and its subsidiary Session M Czech Republic s.r.o. on May 01, 2026, acquiring 100% shareholding from previous owner Mastercard Inc. The transaction was executed through Capillary's wholly owned subsidiary Capillary Pte. Ltd., following regulatory compliance under SEBI LODR Regulations and completion of all closing conditions disclosed in February 2026.
29Apr 26
Capillary Technologies Schedules Q4 FY26 Earnings Conference Call for May 6, 2026
Capillary Technologies India Limited has scheduled its Q4 FY26 earnings conference call for May 6, 2026 at 4:00 PM IST, following the announcement of financial results for the quarter and year ended March 31, 2026. The company has informed BSE and NSE about this investor interaction as per SEBI Listing Regulations, with Sunil Jain serving as the contact person for investor relations. The call details and materials will be available on the company's investor website.
22Apr 26
Capillary Technologies Allots 64,680 Equity Shares Under ESOP Plan 2021
Capillary Technologies India Limited completed allotment of 64,680 equity shares under its ESOP Plan 2021 following approval by the Nomination and Remuneration Committee on April 16, 2026. The shares were issued at par value and exercise price of ₹ 2/- each with no premium, bringing the total issued shares to 7,94,71,983 and share capital to Rs.15,89,43,966.
16Apr 26
Capillary Technologies Files Initial Disclosure for FY 2025-26 with Outstanding Borrowings of ₹44.72 Crore
Capillary Technologies India Limited submitted its initial disclosure for FY 2025-26, reporting outstanding borrowings of ₹44.72 crore as of March 31, 2026. The company confirmed it does not qualify as a 'Large Corporate' under SEBI framework, making certain borrowing requirements inapplicable. The disclosure was filed with BSE and NSE on April 16, 2026, signed by Company Secretary Gireddy Bhargavi Reddy and CFO Anant Choubey from Bengaluru.
11Apr 26
Capillary Technologies India Limited Files SEBI Compliance Certificate for Q4FY26
Capillary Technologies India Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 10, 2026. The certificate from RTA MUFG Intime India Private Limited confirmed no demat requests were processed during the quarter as all shares remain in electronic mode. Company Secretary Gireddy Bhargavi Reddy filed the document with BSE and NSE, fulfilling regulatory obligations.
07Apr 26
Capillary Technologies India Limited Schedules Analyst and Institutional Investor Meeting for April 10, 2026
Capillary Technologies India Limited has scheduled a virtual analyst and institutional investor meeting for April 10, 2026, at 12:00 PM, as announced through regulatory filings on April 07, 2026. The company has confirmed that no Unpublished Price Sensitive Information will be discussed during the group interaction, and the meeting schedule may be subject to changes due to participant or company exigencies.
02Apr 26
Capillary Technologies Appoints Sumit Kumar as President of Middle East, Africa & India
Capillary Technologies has appointed Sumit Kumar as President of Middle East, Africa & India, effective April 02, 2026. Kumar brings 28 years of experience from leadership roles at Marks & Spencer, Bata, Landmark Group, Al-Futtaim, and The Clermont Group. Based in Dubai, he will lead sales strategy and client expansion across these strategic markets. The appointment strengthens Capillary's leadership team as it focuses on driving growth in the loyalty technology solutions space.
02Apr 26
Capillary Technologies Grants 6,563 Stock Options Under ESOP Plan 2021
Capillary Technologies India Limited granted 6,563 stock options under ESOP Plan 2021 to eligible employees at ₹475 per option, offering a 19.85% discount to fair market value. The options vest over four years and can be exercised within 10 years from vesting or 12 years from listing date. The grant was approved on April 01, 2026, and complies with SEBI regulations for employee stock option schemes.
19Mar 26
Capillary Technologies India Limited Schedules Analyst Meet for March 24, 2026
Capillary Technologies India Limited has scheduled a virtual analyst and institutional investor meeting for March 24, 2026, from 03:30 p.m. to 04:30 p.m. The company has informed BSE and NSE about this group meeting under SEBI Listing Regulations. The company clarified that no UPSI will be discussed and the schedule may be subject to changes due to participant or company requirements.
13Mar 26
Capillary Technologies Completes ESOP Extension Postal Ballot with 86.48% Approval
Capillary Technologies India Limited successfully completed its postal ballot process for extending ESOP 2021 benefits to subsidiary employees with 86.48% shareholder approval. The remote e-voting process, conducted from February 11 to March 12, 2026, saw 70.95% participation across 79.31 million shares, with promoter group showing 100% support and public non-institutions achieving 99.99% approval rate.
12Mar 26
Capillary Technologies Allots 95,530 Equity Shares Under ESOP Plan 2021
Capillary Technologies India Limited allotted 95,530 equity shares under ESOP Plan 2021 on March 12, 2026, at ₹ 2 per share exercise price. The allotment increased total issued shares to 79407303 and share capital to ₹ 15,88,14,606. The shares rank pari passu with existing equity shares and are listed on NSE and BSE without any lock-in restrictions.
04Mar 26
Capillary Technologies Signs $20 Million Five-Year Deal with Fortune 50 US Retailer
Capillary Technologies India Limited announced a major five-year strategic partnership worth more than $20 million with a Fortune 50 US retailer. The deal positions Capillary as the strategic partner to modernize the retailer's loyalty and customer engagement ecosystem using AI-powered solutions, including enhanced personalization, AI-driven offer optimization through the aiRA engine, and real-time customer intelligence capabilities.
26Feb 26
Capillary Technologies Board Approves USD 20M SessionM Acquisition Strategy
Capillary Technologies India Limited received board approval for acquiring 100% shareholding in Session M Inc. from Mastercard for USD 20 million base consideration. The board meeting held on February 24, 2026, approved the transaction through wholly owned subsidiary Capillary Pte. Ltd., with completion expected within 180 days. SessionM, founded in 2011, recorded USD 50.50 million turnover in CY2025 and operates as a cloud-based loyalty platform serving North American, LATAM, and APAC markets.
24Feb 26
Capillary Technologies Clarifies ESOP Exercise Price Mechanism Following Proxy Advisor Feedback
Capillary Technologies India Limited issued a clarification on February 24, 2026, addressing proxy advisor concerns about exercise price determination under its ESOP 2021 scheme extension to subsidiary employees. The company clarified that exercise prices will be set by the Nomination and Remuneration Committee with a maximum 20% discount to the 90-day VWAP, ensuring objective and market-linked pricing. The clarification supports Special Resolution No. 1 in the company's postal ballot notice dated February 06, 2026, seeking shareholder approval for extending ESOP benefits to subsidiary employees in India and overseas.
12Feb 26
Capillary Technologies Reports 16% Revenue Growth in Q3 FY26 Earnings Call
Capillary Technologies India Limited reported strong Q3 FY26 results with 16% revenue growth to INR 184 crores and 24% adjusted EBITDA growth to INR 30 crores. Nine-month revenue reached INR 543 crores (22% growth) with adjusted EBITDA of INR 71 crores (53% growth). The company maintained 111% net retention rate and added INR 66 crores in new order book, while strengthening its market leadership position in loyalty management platforms.
06Feb 26
Capillary Technologies India Limited Schedules Multiple Investor Meetings in Mumbai for February 11-13, 2026
Capillary Technologies India Limited has scheduled multiple analyst and investor meetings for February 11-13, 2026 in Mumbai, disclosed under SEBI Regulation 30. All meetings will be conducted physically in Mumbai across three consecutive days. The company has clarified that no Unpublished Price Sensitive Information will be discussed and noted that schedules may change due to participant or company requirements.
02Feb 26
Capillary Technologies India Limited Schedules Q3FY26 Earnings Conference Call for February 6, 2026
Capillary Technologies India Limited has scheduled its Q3FY26 earnings conference call for February 6, 2026 at 4:30 PM IST to discuss results for the quarter ended December 31, 2025. The call will feature key management including CEO Aneesh Reddy Boddu, CFO Anant Choubey, and other senior executives. The AI-based SaaS solutions provider serves enterprise customers globally with loyalty development solutions.
05Jan 26
Capillary Technologies Completes ESOP 2021 Ratification with 89.11% Shareholder Approval
Capillary Technologies India Limited successfully completed postal ballot for ESOP 2021 ratification with 89.11% shareholder approval. The voting process concluded on January 04, 2026, with promoter group showing unanimous support while public institutions were split. The company filed comprehensive regulatory documents with stock exchanges, enabling implementation of employee stock option program covering up to 72,91,000 options.
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
